
ATMI Invests in Sterile Fill and Connector Technology
ATMI has invested in sterile-connector and sterile-fill technology developed by Medical Instill Technologies.
The investments focus on the INTACT family of products developed by Medinstill. These technologies will be deployed in sterile filling, sterile multiple-dose dispensing, sterile transfer, and packaging sterilization solutions.
In other news, ATMI has introduced a line of
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.